Advertisement
BHC vs COLL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and COLL is a StrongBuy.
BHC in +5.53% Uptrend, advancing for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BHC advanced for three days, in 212 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
BHC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BHC crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 115 of 155 cases where BHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The 10-day RSI Indicator for BHC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 30 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 56 cases where BHC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
BHC broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.727) is normal, around the industry mean (6.379). P/E Ratio (-2.782) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.011) is also within normal values, averaging (2.202). BHC has a moderately high Dividend Yield (0.489) as compared to the industry average of (0.062). P/S Ratio (0.197) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
COLL in upward trend: price rose above 50-day moving average on October 29, 2026
COLL moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on COLL as a result. In 66 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The 10-day moving average for COLL crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +4.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in 220 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 174 of 230 cases where COLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
Bearish Trend Analysis
The 10-day RSI Indicator for COLL moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 30 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 59 cases where COLL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 66%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
COLL broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 50 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.527) is normal, around the industry mean (6.379). P/E Ratio (16.033) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.664) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.995) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. COLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COLL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
BHC | COLL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 26 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 2 Undervalued | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 89 | |
SMR RATING 1..100 | 100 | 50 | |
PRICE GROWTH RATING 1..100 | 35 | 60 | |
P/E GROWTH RATING 1..100 | 98 | 87 | |
SEASONALITY SCORE 1..100 | n/a | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BHC's Valuation (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for COLL (58). This means that BHC’s stock grew somewhat faster than COLL’s over the last 12 months.
COLL's Profit vs Risk Rating (89) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that COLL’s stock grew similarly to BHC’s over the last 12 months.
COLL's SMR Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that COLL’s stock grew somewhat faster than BHC’s over the last 12 months.
BHC's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as COLL (60). This means that BHC’s stock grew similarly to COLL’s over the last 12 months.
COLL's P/E Growth Rating (87) in the Pharmaceuticals Other industry is in the same range as BHC (98). This means that COLL’s stock grew similarly to BHC’s over the last 12 months.
| BHC | COLL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 66% |
| Momentum ODDS (%) | N/A | 1 day ago 69% |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 1 day ago 74% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 71% | 1 day ago 71% |
| Advances ODDS (%) | 3 days ago 76% | 14 days ago 70% |
| Declines ODDS (%) | 10 days ago 77% | 10 days ago 69% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 76% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BHC’s FA Score shows that 1 FA rating(s) are green while COLL’s FA Score has 0 green FA rating(s).
- BHC’s FA Score: 1 green, 4 red.
- COLL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BHC’s TA Score shows that 4 TA indicator(s) are bullish while COLL’s TA Score has 5 bullish TA indicator(s).
- BHC’s TA Score: 4 bullish, 4 bearish.
- COLL’s TA Score: 5 bullish, 4 bearish.
Price Growth
BHC (@Pharmaceuticals: Generic) experienced а +1.84% price change this week, while COLL (@Pharmaceuticals: Generic) price change was +4.82% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
BHC is expected to report earnings on Feb 24, 2027.
COLL is expected to report earnings on Feb 25, 2027.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
BHC and
Correlation & Price change
A.I.dvisor tells us that BHC and AMPH have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMPH's prices will move in lockstep.
| Ticker / NAME | Correlation To BHC | 1D Price Change % | ||
|---|---|---|---|---|
| BHC | 100% | +0.72% | ||
| AMPH - BHC | 30% Poorly correlated | -1.58% | ||
| HCM - BHC | 28% Poorly correlated | -1.95% | ||
| ZSTK - BHC | 25% Poorly correlated | +4.74% | ||
| COLL - BHC | 24% Poorly correlated | +1.39% | ||
| ANIP - BHC | 24% Poorly correlated | -0.22% | ||
More | ||||
COLL and
Correlation & Price change
A.I.dvisor indicates that over the last year, COLL has been loosely correlated with VTRS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then VTRS could also see price increases.
| Ticker / NAME | Correlation To COLL | 1D Price Change % | ||
|---|---|---|---|---|
| COLL | 100% | +1.39% | ||
| VTRS - COLL | 42% Loosely correlated | +1.01% | ||
| EBS - COLL | 40% Loosely correlated | -0.17% | ||
| AMPH - COLL | 36% Loosely correlated | -1.58% | ||
| SNDL - COLL | 33% Loosely correlated | +2.16% | ||
| AMRX - COLL | 32% Poorly correlated | +1.54% | ||
More | ||||